Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)

Go back to Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)
Bristol-Myers Squibb (NYSE: BMY) Delayed: 64.41 +0.71 (1.11%)
Previous Close $63.70    52 Week High $77.12 
Open $64.05    52 Week Low $49.03 
Day High $64.68    P/E 41.82 
Day Low $63.91    EPS $1.54 
Volume 1,398,060       

Gilead Sciences (NASDAQ: GILD) Delayed: 137.25 +1.38 (1.02%)
Previous Close $135.87    52 Week High $108.63 
Open $136.94    52 Week Low $71.39 
Day High $137.91    P/E 75.83 
Day Low $136.03    EPS $1.81 
Volume 629,947       

Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) Delayed: 24.50 --0 (-0%)
Previous Close $24.50    52 Week High $24.50 
Open $9.18    52 Week Low $4.81 
Day High $24.50    P/E N/A 
Day Low $24.50    EPS $-0.89 
Volume 5,300       

Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Delayed: 525.99 +0.26 (0.05%)
Previous Close $525.73    52 Week High $134.71 
Open $528.68    52 Week Low $73.31 
Day High $529.00    P/E N/A 
Day Low $522.57    EPS $-1.98 
Volume 85,490